MAGGI, ROBERTO
MAGGI, ROBERTO
Dipartimento di Scienze Farmaceutiche
24-dehydrocholesterol reductase, the affected enzyme in desmosterolosis, a severe inherited disorder of cholesterol metabolism
2011 D. Zucchini, I. Madaschi, M. Galbiati, R. Maggi, A. Aliverti, G. Tedeschi, D. Caruso, M.A. Vanoni
24-dehydrocholesterol reductase, the affected enzyme in desmosterolosis, a severe inherited disorder of cholesterol metabolism
2013 D. Zucchini, I. Madaschi, M. Galbiati, R. Maggi, A. Aliverti, G. Tedeschi, D. Caruso, M.A. Vanoni
A novel dominant-negative FGFR1 variant causes Hartsfield syndrome by deregulating RAS/ERK1/2 pathway
2019 P. Palumbo, A. Petracca, R. Maggi, T. Biagini, G. Nardella, M. Carmine Sacco, E. Di Schiavi, M. Carella, L. Micale, M. Castori
Ageing of the neuroendocrine system in the brain of male rats: receptor mechanisms and steroid metabolism
1993 F. Piva, F. Celotti, D. Dondi, P. Limonta, R. Maggi, E. Messi, P. Negri-Cesi, M. Zanisi, M. Motta, L. Martini
Aging and the hypothalamic-pituitary complex of the male rat
1986 F. Piva, M. Zanisi, E. Messi, R. Maggi, F. Celotti, P. Negri-Cesi, M. Motta, L. Martini
Aging and the hypothalamo-pituitary-testicular axis in the rat
1987 F. Piva, P. Limonta, R. Maggi, D. Dondi, E. Messi, M. Zanisi, M. Motta
Alpha7 and alpha8 nicotinic receptor subtypes immunopurified from chick retina have different immunological, pharmacological and functional properties
1997 C. Gotti, M. Moretti, R. Maggi, R. Longhi, W. Hanke, N. Klinke, F. Clementi
Altered expression of 3-betahydroxysterol delta-24-reductase/selective Alzheimer's disease indicator-1 gene in Huntington's disease models
2014 A. Samara, M. Galbiati, P. Luciani, C. Deledda, E. Messi, A. Peri, R. Maggi
Androgen and progesterone metabolism in the central and peripheral nervous system
1993 L. Martini, R. C. Melcangi, R. Maggi
ANOS1 : a unified nomenclature for Kallmann syndrome 1 gene (KAL1) and anosmin-1
2017 F. de Castro, R. Seal, R. Maggi
Anosmin-1-Like Effect of UMODL1/Olfactorin on the Chemomigration of Mouse GnRH Neurons and Zebrafish Olfactory Axons Development
2022 E. Di Schiavi, G. Vistoli, R.M. Moretti, I. Corrado, G. Zuccarini, S. Gervasoni, L. Casati, D. Bottai, G.R. Merlo, R. Maggi
Antiprogestins inhibit the binding of opioids to mu-opioid receptors in nervous membrane preparations
1996 R. Maggi, F. Pimpinelli, L.A. Casulari, F. Piva, L. Martini
Antiproliferative action of melatonin on human prostate cancer LNCaP cells
2000 R.M. Moretti, M. Montagnani Marelli, R. Maggi, D. Dondi, M. Motta, P. Limonta
Antiproliferative action of RU486 on human neuroblastoma cells (SK-N-SH)
2007 D. Dondi, L.A. Casulari, M. Piccolella, G. Pratesi, F. Piva, R. Maggi
Antiproliferative effect of mifepristone ({RU}486) on human neuroblastoma cells ({SK}-N-{SH}): in vitro and in vivo studies
2020 L.A. Casulari, D. Dondi, G. Pratesi, F. Piva, M. Milani, M. Piccolella, R. Maggi
Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaP
1992 P. Limonta, D. Dondi, R.M. Moretti, R. Maggi, M. Motta
Aspects of hormonal steroid metabolism in the nervous system
1999 A. Poletti, F. Celotti, R. Maggi, R.C. Melcangi, L. Martini, P. Negri-Cesi
ASSE IPOTALAMO-IPOFISI-GONADI
2010 R. Maggi
Beta-sarcoglycanopathy: any longer an "orphan" disease?
2014 R. Maggi, B. Vola, M. Cerletti, B. Bonetti
Beta-sarcoglycanopathy: what’s new?
2015 B. Vola, R. Maggi, M. Cerletti, Y. Torrente